ARCHIVO DE NOTICIAS
AÑO 2006
¡17 Nuevos centros de tratamiento de
SpineCor abiertos en 5 países en el año 2006!
El tratamiento con el Sistema SpineCor está
disponible desde el año 2006 en 17 nuevos centros en Australia, Canadá, España,
Polonia y Estados Unidos.
SpineCor presentado en todo el mundo
Durante el año 2006 se han impartido programas de
formación médica continuada en Alemania, España, Polonia y Estados Unidos.
El Sistema Spinecor también se ha presentado en
varias reuniones y conferencias en todo el mundo durante el 2006.
Se han realizado presentaciones de SpineCor en los siguientes eventos:
-
GES Meeting, París, Francia
-
AAOS Annual Meeting, Chicago, Estados Unidos
-
SOSORT Meeting,
-
SPORC Meeting,
-
13th IMAST Meeting,
-
AOPA National Assembly,
Florida, Estados Unidos
-
AAOP Annual Meeting,
AÑO 2005
1er Encuentro de Consenso del
Grupo Europeo de Estudio del Sistema SpineCor – Alicante, 19 – 20 de Septiembre
de 2005
El 1er Encuentro de Consenso del Grupo
Europeo de Estudio del Sistema Spinecor fue celebrado en Alicante (España) el
19 – 20 de Septiembre de 2005.
El encuentro reunió a profesionales del tratamiento
de la escoliosis de Europa, Asia y Norte América, demostrando ser una gran
oportunidad para intercambiar experiencias y debatir sobre resultados,
preguntas y problemas relacionados con el tratamiento de la escoliosis.
El éxito de la reunión y las conclusiones derivadas
del intercambio de experiencias demostró ser de gran importancia para la mejora
del tratamiento de los pacientes con escoliosis idiopática.
Descargue aquí la foto
del encuentro.
AÑO 2004
Apertura de nuevos centros de SpineCor
El tratamiento con el Sistema Spinecor se ha
introducido por primera vez en Grecia y Alemania.
Celebrado el primer Programa de Formación de
SpineCor para quiroprácticos y osteópatas en Nueva York, Estados Unidos.
AÑO 2003
Hasta ahora el Reino Unido, los
Estados Unidos, Grecia, Israel y España han abierto nuevos centros para ofrecer
el tratamiento con SpineCor. Hungría planea abrir 3 centros nuevos este verano
después de conseguir la aprobación de reembolso del tratamiento.
El Dr. Charles Hilaire Rivard
presentará los últimos resultados del tratamiento con SpineCor en el congreso
de este año que se celebrará en Budapest.
Promobil, el distribuidor exclusivo de los productos SpineCor en
Hungría, exhibirá en el Congreso Interbor. Representantes de The
SpineCorporation, así como el Dr. Rivard y
AÑO 2002
Orthopedics Today publicó un artículo acerca de los últimos
resultados del tratamiento presentados por el Dr. Charles Rivard en el
Congreso.
Cobb angles worsened in 42% of unbraced and 5% of brace patients
studies.
Interim Results of the first prospective randomized study of scoliosis patients
with Cobb angles between 15º and 30º showed that the use of a dynamic back brace
helped prevent worsening of their curves.
Despite unquestionable success with the treatment - only a few of the
braced patients worsened - the study may soon be discontinued due to ethical
concerns, investigators said.
"This interim evaluation represents a strong tendency, where 42% of the
control group worsened compared to the treatment group, which showed a
worsening in only 5% of patients. These interim results, which show a
large difference in worsening between treated and untreated patients, questions
the logic of continuing this prospective randomized study." said Charles
H Rivard, MD of Ste Justine Hospital in Montreal.
Rivard presented results during the 4th Annual Meeting of the Spine Society of
Europe, here.
If scoliosis patients with Cobb angles of this size are not treated, the curves
have a 68% risk of progression, according to the literature, he said. The
dynamic brace Rivard used resulted in aesthetic outcome and patient compliance
that was better than achieved with rigid braces. "The most important
thing is to initial treatment prior to the development of bone structure
deformation," he said.
Investigators randomized 65 children with scoliosis into two
groups. For inclusion, patients had to have scoliosis curves with initial
Cobb angles between 15 and 30º and no contraindications based on a clinical
examination and AP and lateral radiographs. The Risser sign also had to
be 0, 1 or 2 and there had to be a high risk of progression - a Cobb angle
increase of 5º or more in the past six months.
The control group consisted of 36 patients whose mean Cobb angles were 22º, +
or - 5º. The average age of all patients was 12 years.
Patient in the treated group received treatment with the SpineCor Brace (The
SpineCorporation Ltd:
During the study, three patients withdrew from each group. For the
33 patients left in the control group, the mean Cobb angle at the last
examination was 26º + or - 8º, which meant that 45% of control patients were
stable, 12% were improved and 42% worsened. Worsening meant an increase
in Cobb angle of >5º within six months, which investigators confirmed using
radiographs.
For the 20 patients who remained in the treated group, the mean Cobb angle
while braced was 15º + or - 7º. This resulted in improvements in 76% of
treated patients, stability in 14% curve worsening in 5%. The other six
treated patients were weaned off the brace Rivard said.
In a corresponding poster session, the investigators reported the outcomes of
the initial cohort of 195 scoliosis patients treated with the SpineCor
brace. Braced patients had an initial decrease in spine curve.
Stabilization and correction lasted to the end of treatment and was maintained
for one to four years of follow-up.
Rivard, CH, Coillard C, Zabjek KF.
A
prospective randomized study of the natural history of idiopathic scoliosis vs.
treatment with the SpineCor brace. Interim results #35. Presentado en la 4ª Reunión Anual de
